Apex Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	567.09	532.69	382.05	331.71	555.33
Trading Asset Securities	77.28	66.1	61.87	65.83	69.72
Cash & Short-Term Investments	644.37	598.78	443.91	397.53	625.05
Cash Growth	7.61%	34.89%	11.67%	-36.40%	-24.05%
Accounts Receivable	437.8	346.64	288.39	486.77	474.41
Other Receivables	9.81	8.08	5.72	10.12	13.97
Receivables	447.61	354.72	294.11	496.89	488.38
Inventory	561.83	662.49	747.71	739.25	628.59
Prepaid Expenses	-	24.78	18.51	19	11.06
Other Current Assets	19.79	2.29	2.4	1.81	6.78
Total Current Assets	1,674	1,643	1,507	1,654	1,760
Property, Plant & Equipment	652.64	695.81	720.59	766.08	794.12
Long-Term Investments	6.2	-	-	-	-
Other Intangible Assets	35.71	39.6	44.22	69.14	106.48
Long-Term Deferred Tax Assets	12.8	9.24	4.24	3.62	0.43
Other Long-Term Assets	34.86	32.23	21.32	21.38	9.58
Total Assets	2,416	2,420	2,297	2,515	2,670
Accounts Payable	231.7	239.03	156.22	289.69	343.89
Accrued Expenses	12.18	142.25	133.43	150.55	148.07
Short-Term Debt	-	-	30	50	150
Current Portion of Leases	7.69	9.03	7.2	8.01	6.88
Current Income Taxes Payable	25.88	24.52	46.24	36.92	40.12
Current Unearned Revenue	7.23	58.28	6.6	29.04	93.06
Other Current Liabilities	147.37	4.68	3.67	6.35	3.87
Total Current Liabilities	432.05	477.78	383.35	570.55	785.89
Long-Term Leases	101.98	113.93	116.2	122.67	127.66
Long-Term Deferred Tax Liabilities	10.82	3.54	0.04	3.1	2.88
Other Long-Term Liabilities	0.47	0.47	0.48	0.49	0.48
Total Liabilities	545.32	595.7	500.07	696.81	916.91
Common Stock	999.5	999.5	999.5	999.5	999.5
Additional Paid-In Capital	68.37	68.37	68.37	68.37	68.37
Retained Earnings	791.23	744.06	718.87	739.95	682.34
Comprehensive Income & Other	10.61	11.67	9.69	9.51	2.52
Total Common Equity	1,870	1,824	1,796	1,817	1,753
Minority Interest	0.77	0.63	0.5	0.57	0.82
Shareholders' Equity	1,870	1,824	1,797	1,818	1,754
Total Liabilities & Equity	2,416	2,420	2,297	2,515	2,670
Total Debt	109.67	122.96	153.4	180.68	284.55
Net Cash (Debt)	534.69	475.83	290.52	216.85	340.5
Net Cash Growth	12.37%	63.79%	33.97%	-36.31%	10.11%
Net Cash Per Share	5.32	4.74	2.90	2.15	3.22
Filing Date Shares Outstanding	99.88	99.95	99.95	99.95	99.95
Total Common Shares Outstanding	99.88	99.95	99.95	99.95	99.95
Working Capital	1,242	1,165	1,123	1,084	973.97
Book Value Per Share	18.72	18.25	17.97	18.18	17.54
Tangible Book Value	1,834	1,784	1,752	1,748	1,646
Tangible Book Value Per Share	18.36	17.85	17.53	17.49	16.47
Land	-	261.68	261.68	261.68	261.68
Buildings	-	605.02	604.13	604.13	601.96
Machinery	-	806.49	789.71	777.35	754.25

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.